 | This article needs additional citations for verification .(September 2014) |
The Robert J. And Claire Pasarow Foundation Medical Research Awards were awarded annually for distinguished accomplishment in areas of investigation that included neuropsychiatry, cardiovascular disease, and cancer research. The program ran from 1987 to 2013. [1] Each area of research was allocated US$50,000 to award to its winners.
The Pasarow Foundation was created in 1987 by Mr. and Mrs. Pasarow of Beverly Hills, California, to stimulate medical and scientific research. Robert Pasarow was the founder and former president/CEO/chairman of the board of CHB Foods, Inc. The Pasarows established the Claire and Robert J. Pasarow Cancer Laboratory at the Kenneth Norris Jr. Cancer Hospital and Research Institute at the University of Southern California as well as the Pasarow Mass Spectrometry Laboratory at the University of California Los Angeles. Robert J. Pasarow, now deceased, was the founding president and chairman of the foundation and Claire Pasarow, also deceased, was the chief financial officer.
The members of the board of directors were:
The principal criterion for nomination was evidence of extraordinary accomplishment in medical science.
Nominators provided a one-page letter of intent stating the rationale for the nomination and a copy of the nominee's curriculum vitae and bibliography in two-page NIH format. Applications were reviewed by the board of directors in consultation with various medical scholars.
| Year | Cancer Award | Cardiovascular Award | Neuropsychiatry Award |
|---|---|---|---|
| 1987 | Peter K. Vogt, Ph.D., University Of Southern California | Burton E. Sobel , M.D., Washington University | Nancy S. Wexler |
| 1988 | Irving Weissman, M.D., Stanford University | Harvey Feigenbaum, M.D., Indiana University | Eric Kandel |
| 1989 | George F. Vande Woude, Ph.D., National Cancer Institute | Bernardo Nadal-Ginard , M.D., Ph.D., Harvard University | Floyd Bloom |
| 1990 | Erkki Ruoslahti, M.D., La Jolla Cancer Research Foundation | Mordecai P. Blaustein , M.D., University of Maryland | Solomon H. Snyder |
| 1991 | Harold M. Weintraub, M.D., Ph.D., Fred Hutchinson Research Center | Jonathan G. Seidman , Ph.D. & Christine E. Seidman, M.D., Harvard University | Michael E. Phelps |
| 1992 | Ronald M. Evans, Ph.D., The Salk Institute for Biological Studies | Glenn A. Langer , M.D., UCLA School of Medicine | Patricia Goldman-Rakic |
| 1993 | Stanley Korsmeyer, M.D., Washington University | Philip Majerus, M.D., Washington University | Huda Akil and Stanley Watson |
| 1994 | Carlo M. Croce, M.D., Jefferson Cancer Center | Jan L. Breslow, M.D., Rockefeller University | Arvid Carlsson, Philip Seeman |
| 1995 | Alfred G. Knudson, Jr., M.D., Ph.D., Fox Chase Cancer Center | Kenneth R. Chien, M.D., Ph.D., University of California, San Diego | Stanley Prusiner |
| 1996 | Robert A. Weinberg, M.D., MIT and Whitehead Institute | Michael Anthony Gimbrone , Jr., M.D., Harvard University | Joseph T. Coyle |
| 1997 | Eric S. Lander, DPhil, MIT | Masashi Yanagisawa, M.D., Ph.D., University of Texas, Southwestern | Eric J. Nestler |
| 1998 | Paul L. Modrich, Ph.D., Duke University | Mark T. Keating , M.D., University of Utah | Fred Gage |
| 1999 | Anthony S. Fauci, M.D., NIH | Eric N. Olson, Ph.D., University of Texas Southwestern Medical Center | Michael I. Posner and Marcus Raichle |
| 2000 | Alexander J. Varshavsky, Ph.D., California Institute of Technology | Richard P. Lifton, M.D., Ph.D., Yale School of Medicine | Pasko Rakic |
| 2001 | Tom Maniatis, Ph.D., Harvard University | Robert J. Lefkowitz, M.D., Duke University Medical Center | Seymour Benzer |
| 2002 | Roger D. Kornberg, Ph.D., Stanford University | Shaun Coughlin , M.D., Ph.D., University of California, San Francisco | Tomas Hökfelt |
| 2003 | Elizabeth H. Blackburn, Ph.D., F.R.S., University of California San Francisco | Judah Folkman, M.D. Harvard Medical School and Children's Hospital | Thomas Jessell |
| 2004 | Frederick W. Alt, Ph.D., Harvard Medical School and Children's Hospital | Barry S. Coller, M.D, Rockefeller University | Judith L. Rapoport |
| 2005 | Bert W. O'Malley, M.D., Baylor College of Medicine | Douglas C. Wallace, Ph.D., University of California at Irvine | Bruce McEwen |
| 2006 | Tony Hunter, Ph.D., Salk Institute for Biological Studies [2] | Daniel Steinberg , M.D., Ph.D., University of California | Huda Zoghbi |
| 2007 | Bert Vogelstein, M.D., Johns Hopkins University | Richard O. Hynes, Ph.D., Massachusetts Institute of Technology | Aaron T. Beck |
| 2008 | Not awarded | ||
| 2009 | Not awarded | ||
| 2010 | Inder M. Verma, Ph.D., Salk Institute, Brian J. Druker, M.D., Oregon Health & Science University and Howard Hughes Medical Institute | David Ginsburg , M.D., University of Michigan Medical School | Jean-Pierre Changeux |
| 2011 | Angela H. Brodie, Lewis C. Cantley, Joan A. Steitz | Jeffrey M. Friedman, Andrew Marks, Gerald Reaven | Robert Malenka, Roger Nicoll, Charles F. Stevens |
| 2012 | David M. Livingston, Joan Massagué, Michael G. Rosenfeld | Antonio M. Gotto, Robert W. Mahley , Peter J Ratcliffe FRS, Nuffield Department of Medicine, University of Oxford | Virginia M.-Y. Lee, Ph.D., University of Pennsylvania [3] Christine Petit, John Q. Trojanowski |
| 2013 | Elaine Fuchs, Ph.D., The Rockefeller University; Richard Peto, University of Oxford; Matthew P. Scott, Ph.D., Stanford University | Harry C. Dietz , M.D., Johns Hopkins University; Charles T. Esmon , Ph.D., University of Oklahoma; Helen Hobbs, M.D., University of Texas Southwestern | Karl Deisseroth, M.D., Ph.D., Stanford University; Helen S. Mayberg, M.D., Emory University; Carla Shatz, Ph.D., Stanford University |
The Salk Institute for Biological Studies is a scientific research institute located in the La Jolla community of San Diego, California, U.S. The independent, non-profit institute was founded in 1960 by Jonas Salk, the developer of the polio vaccine; among the founding consultants were Jacob Bronowski and Francis Crick. Construction of the research facilities began in spring of 1962. The Salk Institute consistently ranks among the top institutions in the US in terms of research output and quality in the life sciences. In 2004, the Times Higher Education Supplement ranked Salk as the world's top biomedicine research institute, and in 2009 it was ranked number one globally by ScienceWatch in the neuroscience and behavior areas.
Elizabeth Helen Blackburn, is an Australian-American Nobel laureate who is the former president of the Salk Institute for Biological Studies. Previously she was a biological researcher at the University of California, San Francisco, who studied the telomere, a structure at the end of chromosomes that protects the chromosome. In 1984, Blackburn co-discovered telomerase, the enzyme that replenishes the telomere, with Carol W. Greider. For this work, she was awarded the 2009 Nobel Prize in Physiology or Medicine, sharing it with Greider and Jack W. Szostak, becoming the first Australian woman Nobel laureate. She also worked in medical ethics, and was controversially dismissed from the Bush administration's President's Council on Bioethics.
Ronald Mark Evans is an American Biologist, Professor and Head of the Salk’s Gene Expression Laboratory, and the March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute for Biological Studies in La Jolla, California and a Howard Hughes Medical Institute Investigator. Dr. Ronald M. Evans is known for his original discoveries of nuclear hormone receptors (NR), a special class of transcriptional factor, and the elucidation of their universal mechanism of action, a process that governs how lipophilic hormones and drugs regulate virtually every developmental and metabolic pathway in animals and humans. Nowadays, NRs are among the most widely investigated group of pharmaceutical targets in the world, already yielding benefits in drug discovery for cancer, muscular dystrophies, osteoporosis, type II diabetes, obesity, and cardiovascular diseases. His current research focuses on the function of nuclear hormone signaling and their function in metabolism and cancer.
Fred "Rusty" Gage is the President of the Salk Institute for Biological Studies and the Adler Professor in the Laboratory of Genetics at the Salk Institute, and has concentrated on the adult central nervous system and the unexpected plasticity and adaptability that remains throughout the life of all mammals. His work may lead to methods of replacing brain tissue lost to stroke or Alzheimer's disease and repairing spinal cords damaged by trauma. He was the President-elect of the ISSCR in 2012.
NYU Grossman School of Medicine is a medical school of New York University, a private research university in New York City. It was founded in 1841 and is one of two medical schools of the university, with the other being the Long Island School of Medicine. NYU Grossman School of Medicine is part of NYU Langone Health, named after Kenneth Langone, the investment banker and financial backer of The Home Depot.
William Ralph Brody is an American radiologist and academic administrator. He was the President of The Johns Hopkins University, a position which he held from 1996 to 2009 before becoming the President of the Salk Institute from 2009 to 2015.
The Gruber Prize in Genetics, established in 2001, is one of three international awards worth US$500,000 made by the Gruber Foundation, a non-profit organization based at Yale University in New Haven, Connecticut.
Robert Alan Good NAM, NAS, AAAS was an American physician who performed the first successful human bone marrow transplant between persons who were not identical twins. He is regarded as a founder of modern immunology.
Thomas Dean Pollard is a prominent educator, cell biologist and biophysicist whose research focuses on understanding cell motility through the study of actin filaments and myosin motors. He is Sterling Professor of Molecular, Cellular & Developmental Biology and a Professor of Cell Biology and Molecular Biophysics & Biochemistry at Yale University. He was Dean of Yale's Graduate School of Arts and Sciences from 2010 to 2014, and President of the Salk Institute for Biological Studies from 1996 to 2001.
Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.
Hans Popper was an Austrian-born pathologist, hepatologist and teacher. Together with Dame Sheila Sherlock, he is widely regarded as the founding father of hepatology. He is the namesake of the Hans Popper Hepatopathology Society, as well as the International Hans Popper Award and the Hans Popper Hepatopathology Society.
Peter K. Vogt is an American molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.
James Patrick Allison is an American immunologist and Nobel laureate who holds the position of professor and chair of immunology and executive director of immunotherapy platform at the MD Anderson Cancer Center at the University of Texas.
The Szent-Györgyi Prize for Progress in Cancer Research, established by National Foundation for Cancer Research (NFCR) and named in honor of Albert Szent-Györgyi, Nobel Laureate and co-founder of NFCR, has been awarded annually since 2006 to outstanding researchers whose scientific achievements have expanded the understanding of cancer and whose vision has moved cancer research in new directions. The Szent-Györgyi Prize honors researchers whose discoveries have made possible new approaches to preventing, diagnosing and/or treating cancer. The Prize recipient is honored at a formal dinner and award ceremony and receives a $25,000 cash prize. In addition, the recipient leads the next "Szent-Györgyi Prize Committee" as honorary chairman.
Garth L. Nicolson is an American biochemist who made a landmark scientific model for cell membrane, known as the Fluid Mosaic Model. He is the founder of The Institute for Molecular Medicine at California, and he serves as the President, Chief Scientific Officer and Emeritus Professor of Molecular Pathology. He is also Conjoint Professor in the Faculty of Science and Technology, University of Newcastle, Australia. During the outbreak of the Gulf War syndrome, he was the leading authority on the study of the cause, treatment and prevention of the disease. He was appointed Chairman of the Medical-Scientific Panel for the Persian Gulf War Veterans Conference. On suspicion of the bacterium that caused the disease as a product of biological warfare, he made extensive scientific investigations and served as authority to the United States House of Representatives. For his service he was conferred honorary Colonel of the US Army Special Forces and honorary US Navy SEAL.
Anthony Rex Hunter is a British-American biologist who is a Professor of Biology at the Salk Institute for Biological Studies and the University of California San Diego. His research publications list his name as Tony Hunter.
David M. Livingston was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana-Farber Cancer Institute. Dr. Livingston joined the Harvard faculty in 1973. His research focused on breast and ovarian cancer.
George F. Vande Woude was a scientist and former director at Van Andel Research Institute in Michigan studying breast cancer.
Kenneth R. Chien is an American doctor and medical scientist who has been a research director at Karolinska Institute, in Stockholm, since 2013. Chien has several papers with over 1,000 citations and a h-index of 132. His area of expertise is cardiovascular science. His research into regenerative cardiovascular medicine, specifically while director of the Cardiovascular Program of the Harvard Stem Cell Institute, led to his co-founding, in 2010, of ModeRNA Therapeutics. In 2018, the company re-branded as Moderna, Inc. Chien is a recipient of the Walter Bradford Cannon Award of the American Physiology Society and the Pasarow Award. He is a member of the Norwegian Academy of Science and Letters, the Austrian Academy of Sciences, and has received an honorary doctorate from the University of Edinburgh.